Skip to content

Author

Adam Miler

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

RUMINATION SYNDROME: A NARRATIVE REVIEW OF AN UNDERRECOGNIZED FUNCTIONAL GASTROINTESTINAL DISORDER

Background Rumination syndrome is an underrecognized disorder of gut–brain interaction characterized by recurrent, effortless postprandial regurgitation resulting from maladaptive behavioral and gastrointestinal motor mechanisms. Although growing evidence has improved understanding of its epidemiology, pathophysiology,...

Filip Chodań, Karol Kajda, Estera Sośniecka et al. · 0 citations
Review Open access Aug 2026

CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING: RISK STRATIFICATION, CURRENT MANAGEMENT, AND ADJUNCTIVE THERAPIES - NARRATIVE REVIEW

Background Chemotherapy induced nausea and vomiting remain among the most common adverse effects of anticancer treatment, affecting up to 80% of patients. Despite effective antiemetic prophylaxis, complete symptom control is not consistently achieved, particularly for nausea and delayed CINV. These symptoms impair qual...

Filip Chodań, Dagmara Laufer, Olga Klimczak et al. · 0 citations
Review Open access Aug 2026

BIOLOGIC AGENTS AND CAR T-CELL THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS: CURRENT EVIDENCE AND CLINICAL PERSPECTIVES - NARRATIVE REVIEW

This review of established and emerging targeted therapies for SLE, including CAR T cell therapy, with emphasis on mechanisms, efficacy, safety, regulatory status, and clinical roles, finds that approaches differ in regulatory status and clinical readiness.

Filip Chodań, Estera Sośniecka, Olga Klimczak et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.